13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001420995
Total reported value
$467.8M
$467.8M
13 檔
135.1%
At the close of Q4 2024, Trustees of Columbia University in the City of New York disclosed equity holdings valued at approximately $467.8M, spread across 13 reported holdings.
Trustees of Columbia University in the City of New York executed strategic sector rebalancing during Q4 2024, establishing 6 new positions while fully exiting 6 holdings and trimming 0 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 99.12% | -1.24% | — | |
| 2 | SNOW | Snowflake Inc | Stock-Tech | 0.26% | — | — | |
| 3 | NU | Nu Holdings Ltd. | Stock-Financials | 0.18% | — | — | |
| 4 | SRZN | Surrozen Inc | Stock-Other | 0.11% | — | — | |
| 5 | QTTB | Q32 Bio Inc | Stock-Other | 0.07% | — | — | |
| 6 | TNYA | Tenaya Therapeutics Inc | Stock-Other | 0.07% | — | — | |
| 7 | VIGL | Vigil Neuroscience Inc | Stock-Other | 0.05% | — | — | |
| 8 | REPX | Riley Exploration Permian In | Stock-Other | 0.04% | — | — | |
| 9 | ✓ | Xilio Therapeutics Inc | Stock-Other | 0.04% | — | — | |
| 10 | METC | Ramaco Resources Inc-a | Stock-Other | 0.03% | — | — | |
| 11 | ✓ | Rapt Therapeutics Inc | Stock-Other | 0.02% | — | — | |
| 12 | VOR | Vor Biopharma Inc. | Stock-Other | 0.02% | — | — | |
| 13 | SRZNW | Surrozen Inc-cw25 | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | +99.1% | NEW | New buy |
| 2 | SNOW | Snowflake Inc | +0.3% | NEW | New buy |
| 3 | NU | Nu Holdings Ltd. | +0.2% | NEW | New buy |
| 4 | QTTB | Q32 Bio Inc | +0.1% | NEW | New buy |
| 5 | REPX | Riley Exploration Permian In | 0% | NEW | New buy |
| 6 | METC | Ramaco Resources Inc-a | 0% | NEW | New buy |
| 7 | SRZNW | Surrozen Inc-cw25 | — | — | Unchanged |
| 8 | ✓ | Xilio Therapeutics Inc | -0.3% | — | Unchanged |
| 9 | LUNG | Pulmonx CORP | -0.3% | EXIT | Sold out |
| 10 | AMPL | Amplitude Inc-class A | -0.3% | EXIT | Sold out |
| 11 | VOR | Vor Biopharma Inc. | -0.4% | — | Unchanged |
| 12 | QS | Quantumscape CORP | -0.7% | EXIT | Sold out |
| 13 | BRK-B | Berkshire Hathaway Inc-cl B | -0.8% | EXIT | Sold out |
| 14 | SRZN | Surrozen Inc | -0.8% | — | Unchanged |
| 15 | VIGL | Vigil Neuroscience Inc | -1.3% | — | Unchanged |
| 16 | BZ | Kanzhun LTD - Adr | -1.9% | EXIT | Sold out |
| 17 | TNYA | Tenaya Therapeutics Inc | -1.9% | — | Unchanged |
| 18 | ✓ | Rapt Therapeutics Inc | -3.8% | — | Unchanged |
| 19 | BRK-A | Berkshire Hathaway Inc-cl A | -87% | EXIT | Sold out |
According to official SEC Form 13F filings, Trustees of Columbia University in the City of New York reported a total U.S. public equity portfolio value of $467.8M across 13 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, SNOW, NU) accounted for 135.1% of total reported equity market value during Q4 2024.
Top New Position Initiated
SPY
市值: $628.2M
Top Position Liquidated / Trimmed
BRK-A
前期市值: $41.2M
During Q4 2024, Trustees of Columbia University in the City of New York's top holdings by market value included SPY (99.1%)、SNOW (0.3%)、NU (0.2%). The largest single position, SPY, represented 99.1% of total portfolio value.
In Q4 2024, Trustees of Columbia University in the City of New York made 12 total portfolio adjustments, initiating 6 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 6 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.